Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ARS-PHARMACEUTICALS-INC-116155892/news/Silverback-Therapeutics-Inc-kundigt-die-FDA-146-S-Akzeptanz-seiner-146-NDA-fur-neffy-E-42064509/?utm_source=whatsapp&utm_medium=social&utm_campaign=share